Research Article

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

Table 1

Prebeta-1 HDL as measured by ELISA in MDCO-216 solutions mixed with buffer or plasma after 1 h incubation at 0 or 37°C. MDCO-216 stock solution contained 13 mg/mL ApoA-I Milano dimer, 6% sucrose, 1% mannitol, and phosphate buffer pH 7.4. Vehicle solution contained 6% sucrose, and 1% mannitol in phosphate buffer, pH 7.4. Solution High (10 mg/mL protein) was prepared by mixing 200 μL MDCO-216 stock with 60 μL Vehicle. Solution Medium (3 mg/mL protein) was prepared by mixing 100 μL MDCO-216 stock with 330 μL Vehicle. Solution Low (1 mg/mL protein) was prepared by mixing 50 μL Solution High with 450 μL Vehicle. 50 μL of these Solutions was spiked into 450 μL Vehicle (Table 1(a)) or into 450 μL plasma (Table 1(b)) and incubated 60 minutes at 0°C or 37°C.
(a)

Solution spikedVehicleLowMediumHigh

Final MDCO-216 concentration
(μg/mL protein):
01003001000

Prebeta-1 HDL in μg/mL (% of added)
Incubated at 0°C012 (12%)44 (15%)118 (12%)
Incubated at 37°C05 (5%)13 (4%)52 (5%)

(b)

Incubation temp.1 h 0°C

Solution spikedVehicleLowMedHigh

Final MDCO-216 concentration
(μg/mL protein):
01003001000

Prebeta-1 HDL net due to plasma
Spiked in plasma 16275101105
Spiked in plasma 2126126131121
Spiked in plasma 3112144143125
Spiked in plasma average100115125117
% of plasma spiked with vehicle115%125%117%

Incubation temp.1 h 37°C

Solution spikedVehicleLowMedHigh

Final MDCO-216 concentration (μg/mL protein):01003001000

Prebeta-1 HDL net due to plasma
Spiked in plasma 1577162379
Spiked in plasma 21289153375
Spiked in plasma 323127173401
Spiked in plasma average1398163385
% of plasma spiked with vehicle733%1220%2888%

Value for MDCO-216 spiked in plasma minus value for MDCO-216 spiked in Vehicle (Table 1(a)) in μg/mL. (value for plasma plus MDCO-216 minus value for MDCO-216 in vehicle)/value for plasma spiked with vehicle.